| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT02340104 | Healthy Volunteers | Drug: Baricitinib|Drug: [^13C4D3^15N]-baricitinib | Eli Lilly and Company | Phase 1 | 2015-01-01 | 2015-03-01 |
| NCT01968057 | Healthy Volunteers | Drug: Baricitinib|Drug: Ciclosporin | Eli Lilly and Company | Phase 1 | 2013-10-01 | 2014-01-08 |
| NCT01870388 | Liver Diseases|Hepatic Insufficiency | Drug: Baricitinib | Eli Lilly and Company | Phase 1 | 2013-06-01 | 2013-09-10 |
| NCT01925144 | Healthy Volunteers | Drug: Baricitinib|Drug: Omeprazole | Eli Lilly and Company | Phase 1 | 2013-10-01 | 2013-11-21 |
| NCT02263911 | Healthy Volunteers | Drug: Baricitinib | Eli Lilly and Company | Phase 1 | 2014-11-01 | 2015-01-05 |
| NCT03026504 | Arteritis, Giant Cell | Drug: Baricitinib | Matthew J Koster|Eli Lilly and Company|Mayo Clinic | Phase 2 | 2017-02-01 | 2017-01-19 |
| NCT01924299 | Healthy Volunteers | Drug: Baricitinib|Drug: Ketoconazole|Drug: Fluconazole | Eli Lilly and Company | Phase 1 | 2013-08-01 | 2013-11-21 |
| NCT01859078 | Healthy Volunteers | Drug: Baricitinib|Drug: Digoxin | Eli Lilly and Company | Phase 1 | 2013-05-01 | 2013-08-23 |
| NCT01896726 | Healthy Volunteers | Drug: Baricitinib|Drug: Microgynon | Eli Lilly and Company | Phase 1 | 2013-07-01 | 2013-10-18 |
| NCT02708095 | Systemic Lupus Erythematosus | Drug: Baricitinib|Drug: Placebo | Eli Lilly and Company | Phase 2 | 2016-03-01 | 2017-03-23 |
| NCT01937026 | Healthy Volunteers | Drug: Baricitinib|Drug: Probenecid | Eli Lilly and Company | Phase 1 | 2013-09-01 | 2013-12-03 |
| NCT02759731 | Chronic Graft vs Host Disease|Chronic Graft-Versus-Host Disease | Drug: Baricitinib | National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC) | Phase 1|Phase 2 | 2016-04-08 | 2017-03-08 |
| NCT02265705 | Rheumatoid Arthritis | Drug: Baricitinib|Drug: Placebo | Eli Lilly and Company | Phase 3 | 2014-10-01 | 2016-07-01 |
| NCT01910311 | Healthy Volunteers | Drug: Baricitinib|Drug: Rifampicin | Eli Lilly and Company | Phase 1 | 2013-08-01 | 2013-10-30 |
| NCT01960140 | Healthy Volunteers | Drug: Baricitinib|Drug: Simvastatin | Eli Lilly and Company | Phase 1 | 2013-10-01 | 2014-01-08 |
| NCT02576938 | Atopic Dermatitis | Drug: Baricitinib|Drug: Placebo|Drug: Triamcinolone (Optional) | Eli Lilly and Company | Phase 2 | 2016-02-01 | 2017-03-14 |
| NCT01885078 | Rheumatoid Arthritis | Drug: Baricitinib|Drug: Placebo | Eli Lilly and Company | Phase 3 | 2013-06-01 | 2017-03-22 |
| NCT01683409 | Diabetic Kidney Disease | Drug: baricitinib|Drug: Placebo | Eli Lilly and Company|Incyte Corporation | Phase 2 | 2012-08-01 | 2015-01-16 |
| NCT01721044 | Rheumatoid Arthritis | Drug: Placebo|Drug: Baricitinib | Eli Lilly and Company | Phase 3 | 2013-01-01 | 2014-09-29 |
| NCT01721057 | Rheumatoid Arthritis | Drug: Placebo|Drug: Baricitinib | Eli Lilly and Company | Phase 3 | 2012-12-01 | 2015-02-19 |
| NCT01490632 | Psoriasis|Skin Diseases|Skin Diseases, Papulosquamous | Drug: Placebo|Drug: LY3009104 | Eli Lilly and Company|Incyte Corporation | Phase 2 | 2011-12-01 | 2014-11-25 |
| NCT01710358 | Rheumatoid Arthritis | Drug: Placebo|Drug: Adalimumab|Drug: Baricitinib | Eli Lilly and Company | Phase 3 | 2012-10-01 | 2016-05-13 |
| NCT01711359 | Rheumatoid Arthritis | Drug: Baricitinib|Drug: Methotrexate|Drug: Placebo|Drug: Folic Acid | Eli Lilly and Company | Phase 3 | 2012-11-01 | 2015-09-24 |
| NCT01299285 | Healthy Volunteers | Drug: LY3009104 | Eli Lilly and Company | Phase 1 | 2011-02-01 | 2011-04-06 |
| NCT02758613 | Healthy | Drug: LY3009104|Drug: Placebo | Eli Lilly and Company | Phase 1 | 2016-05-01 | 2016-08-25 |
